Abstract:
Yttrium-90 selective internal radiation therapy (
90Y-SIRT) has been increasingly applied in the management of hepatic malignancies in China. However, differences remain among medical centers in patient selection, technetium-99m macroaggregated albumin (
99Tc
m-MAA) simulation and evaluation, individualized dose planning, microsphere administration, post-treatment dose verification, and radiation safety management. To standardize comprehensive nuclear medicine management throughout the
90Y-SIRT treatment, this consensus provides standardized recommendations covering key aspects such as patient eligibility and multidisciplinary team (MDT),
99Tc
m-MAA mapping, assessment of lung shunting and tumor targeting, individualized dosimetry, implementation of interventional treatment, post-treatment
90Y PET/CT or SPECT/CT distribution and dose verification, response assessment, long-term follow-up, complication management, and radiation protection. By establishing a standardized practice framework centered on comprehensive nuclear medicine management and incorporating MDT collaboration, this consensus aims to promote safe, standardized, and homogeneous implementation of
90Y-SIRT in China and to provide a reference for medical institutions to establish standard operating procedures, professional training, and quality control systems.